This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Problems related to physical environment
Z21_PROBL_RELATED_PHYSIC_ENVIRONMENT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
316 |
4. Check minimum number of eventsNone |
316 |
5. Include endpointsNone |
316 |
6. Filter based on genotype QC (FinnGen only) |
288 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z5[5-9]|Z6
Similar endpoints
↥List of similar endpoints to
Problems related to physical environment
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to socioeconomic and psychosocial circumstances
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 288 | 219 | 69 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 44.95 | 43.81 | 48.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 297
- Matched controls
- 2970
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z58.8
ICD-10 Finland
Other problems related to physical environment
+∞
292.2
230
*
XQ800
NOMESCO Finland
Prick test
11.2
77.3
99
127
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
15.0
73.3
72
62
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.0
55.1
92
158
J45.1
ICD-10 Finland
Nonallergic asthma
8.8
52.4
77
114
J31.0
ICD-10 Finland
Chronic rhinitis
7.7
50.8
86
149
Z58.1
ICD-10 Finland
Exposure to air pollution
210.4
36.7
37
*
Z2221
NOMESCO Finland
Medical doctor
4.4
35.1
148
549
R03DC03
ATC
montelukast; oral
4.6
33.9
112
345
J45.9
ICD-10 Finland
Asthma, unspecified
4.3
31.4
116
386
Z3231
NOMESCO Finland
Registered nurse
4.1
31.3
142
546
R03BA02
ATC
budesonide; inhalant
4.2
29.7
112
376
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
6.7
27.6
48
83
R03AC02
ATC
salbutamol; inhalant
4.5
26.8
236
1372
R4110
NOMESCO Finland
Physiotherapy
3.6
26.1
136
561
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.3
25.5
83
247
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.8
25.5
106
376
J45
ICD-10 Finland
Asthma
4.4
22.6
66
180
ZXD10
NOMESCO Finland
Scheduled procedure
3.2
21.8
156
761
R03BA05
ATC
fluticasone; inhalant
3.5
21.7
102
387
Z3226
NOMESCO Finland
Physiotherapist
3.6
21.2
92
331
J30.3
ICD-10 Finland
Other allergic rhinitis
6.2
21.2
39
71
T78.4
ICD-10 Finland
Allergy, unspecified
6.5
21.1
37
64
R03BB04
ATC
tiotropium bromide; inhalant
4.7
19.9
52
129
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.7
19.8
78
262
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
6.9
19.2
31
49
S01GX01
ATC
cromoglicic acid; ophthalmic
3.1
18.7
108
458
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.3
17.7
27
40
H02AB07
ATC
prednisone; oral
3.5
17.3
70
238
R06AX27
ATC
desloratadine; oral
2.8
17.2
136
680
R01AD08
ATC
fluticasone; nasal
2.8
16.9
130
639
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
15.4
34
73
R06AX22
ATC
ebastine; oral
2.9
14.8
89
380
Z58.9
ICD-10 Finland
Problem related to physical environment, unspecified
+∞
14.7
14
*
Z58.0
ICD-10 Finland
Exposure to noise
+∞
14.7
14
*
ZXE00
NOMESCO Finland
One hour or less
2.6
14.3
146
811
R01AD05
ATC
budesonide; nasal
3.9
14.1
46
134
R03BB01
ATC
ipratropium bromide; inhalant
5.8
13.8
26
48
R03BA01
ATC
beclometasone; inhalant
3.1
13.5
68
261
Z71.8
ICD-10 Finland
Other specified counselling
2.5
13.5
135
738
R01AD09
ATC
mometasone; nasal
2.5
13.2
181
1139
EB1AA, ,
SPAT
4.0
13.1
40
111
C01CA24
ATC
epinephrine; parenteral
3.8
13.1
43
126
R03DA04
ATC
theophylline; systemic, rectal
5.3
12.9
27
55
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
12.9
97
461
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.6
12.5
45
140
R06AE07
ATC
cetirizine; oral
2.4
12.2
164
1010
J45.8
ICD-10 Finland
Mixed asthma
5.7
12.0
23
43
R06.2
ICD-10 Finland
Wheezing
4.7
11.7
28
64
ZXD20
NOMESCO Finland
Day surgery
3.1
11.6
56
209
R03AC03
ATC
terbutaline; inhalant
2.9
11.3
63
255
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.7
11.3
39
118
R96
ICPC
Asthma
3.2
10.6
47
166
R05
ICD-10 Finland
Cough
2.4
10.5
91
456
R06AX26
ATC
fexofenadine; oral
3.4
10.5
40
129
R06.0
ICD-10 Finland
Dyspnoea
2.4
10.3
99
520
R02
ICPC
Shortness of breath/dyspnoea
2.8
10.2
57
230
H10.4
ICD-10 Finland
Chronic conjunctivitis
11.9
10.2
18
16
J30.0
ICD-10 Finland
Vasomotor rhinitis
5.4
10.0
20
39
J01FA10
ATC
azithromycin; systemic
2.3
10.0
210
1512
Z2446
NOMESCO Finland
Social worker
3.6
9.8
34
103
D01
ICPC
Abdominal pain/cramps general
2.8
9.3
53
216
R06AX13
ATC
loratadine; oral
2.5
9.2
66
301
A02BC05
ATC
esomeprazole; systemic
2.1
9.2
144
912
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
9.2
55
230
R03AC13
ATC
formoterol; inhalant
3.8
9.0
29
83
R03BC03
ATC
nedocromil; inhalant
3.3
9.0
35
114
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.0
9.0
26
69
ZXA10
NOMESCO Finland
Bilateral
2.5
9.0
65
298
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
8.7
114
671
N06AB04
ATC
citalopram; systemic
2.3
8.5
81
419
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.7
8.4
49
201
J01FA09
ATC
clarithromycin; systemic
2.1
8.1
122
752
J01FA06
ATC
roxithromycin; oral
2.0
8.1
141
916
H02AB06
ATC
prednisolone; systemic
2.0
8.1
160
1088
R49.01
ICD-10 Finland
Functional dysphonia
4.2
8.0
22
56
ZXA00
NOMESCO Finland
Right side
2.2
8.0
86
467
R03BA08
ATC
ciclesonide; inhalant
2.7
7.9
45
183
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.9
7.9
38
141
R03AK08
ATC
formoterol and beclometasone; inhalant
3.8
7.7
24
67
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
82.1
7.5
8
*
R01BA52
ATC
pseudoephedrine, combinations; oral
2.0
7.4
116
722
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.6
7.2
46
197
R03AC12
ATC
salmeterol; inhalant
4.0
7.2
21
56
J02AC01
ATC
fluconazole; systemic
1.9
7.2
150
1025
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.9
7.0
34
126
A07AA02
ATC
nystatin; oral
3.4
7.0
26
82
R07.0
ICD-10 Finland
Pain in throat
2.9
6.9
33
122
J01AA02
ATC
doxycycline; systemic
2.3
6.9
249
2050
A01AB04
ATC
amphotericin B; local oral
3.6
6.8
23
68
N03AX16
ATC
[U] pregabalin
2.1
6.8
81
453
A02BC02
ATC
pantoprazole; systemic
2.0
6.8
216
1686
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
6.7
74
402
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.6
123
805
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
6.6
90
530
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
6.6
22
65
A97
ICPC
No disease
2.1
6.5
71
385
U13
ICPC
Bladder symptom/complaint other
6.8
6.4
15
23
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
6.4
51
243
J66.8
ICD-10 Finland
Airway disease due to other specific organic dusts
+∞
6.3
6
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
6.3
43
191
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.2
141
978
D12
ICPC
Constipation
4.3
6.2
16
39
R4120
NOMESCO Finland
Occupational therapy
2.8
6.0
30
113
R2110
NOMESCO Finland
Giving the first information
3.0
6.0
27
96
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
100
383
3.43
20.81
3.1
2.8
1.70
2.91
e6/l
1.18
31
178
100
421
3.07
17.35
3.2
2.7
0.46
0.80
e6/l
1.39
34
216
62
212
3.43
15.02
2.7
2.4
30.63
18.35
au/ml
—
8
17
58
191
3.53
14.89
1.4
1.3
56.68
40.15
au/ml
—
5
13
66
244
3.19
14.04
4.3
2.4
33.42
33.32
u/l
0.01
50
205
213
1507
2.46
11.11
8.4
10.3
3.93
3.99
e9/l
0.16
178
1319
170
1102
2.27
10.75
2.3
2.0
94.93
99.88
pmol/l
0.81
79
563
92
479
2.33
9.65
2.5
2.6
2.41
2.45
mmol/l
3.09
77
438
63
299
2.41
8.02
2.9
2.4
5.05
7.88
umol/l
1.12
52
261
115
698
2.06
7.96
3.6
2.9
0.09
0.34
e6/l
2.07
57
498
180
1292
2.00
7.64
3.6
3.0
82.52
91.79
ug/l
0.44
172
1219
29
95
3.27
7.39
1.7
1.6
5.49
11.77
u/ml
—
8
22
82
451
2.13
7.28
5.6
3.6
287.02
342.95
ng/l
0.09
59
319
156
1094
1.90
6.80
4.0
4.4
37.11
36.58
g/l
0.68
150
1044
34
129
2.85
6.75
3.9
3.3
23.81
24.77
mmol/l
0.69
34
129
46
207
2.45
6.52
2.1
1.4
—
—
—
0
0
26
88
3.14
6.29
1.6
1.2
—
—
—
0
0
263
2242
2.51
6.25
25.0
17.7
331.09
331.84
g/l
0.79
263
2234
132
905
1.83
5.95
3.4
3.2
2.36
2.37
mmol/l
0.13
118
837
17
45
3.95
5.90
1.4
1.1
—
—
—
0
0
17
45
3.95
5.90
1.4
1.1
—
—
—
0
0
218
1769
1.87
5.37
4.6
3.2
—
—
—
0
0
40
187
2.32
5.20
2.6
3.3
4.65
4.52
pmol/l
0.30
35
166
43
782
0.47
4.99
3.3
3.5
0.00
0.00
estimate
-0.00
11
273
93
609
1.77
4.67
2.3
1.6
1.15
1.06
mg/l
0.08
77
483
88
570
1.77
4.57
2.3
1.6
—
—
—
0
0
28
118
2.52
4.56
2.0
1.6
—
—
—
0
0
22
82
2.82
4.53
1.2
1.1
—
—
—
0
0
22
82
2.82
4.53
1.2
1.1
—
—
—
0
0
20
72
2.91
4.38
2.9
2.4
1.00
1.74
index
—
7
38
58
334
1.92
4.37
2.0
1.9
29.34
28.82
s
0.38
58
327
159
1223
1.65
4.29
2.8
2.5
76.06
77.40
nmol/l
0.26
148
1118
47
255
2.00
4.20
2.4
1.8
—
—
—
0
0
29
132
2.33
4.01
6.0
7.6
24.95
25.20
mmol/l
0.14
29
132
21
84
2.61
3.80
1.2
1.2
—
—
—
0
0
25
109
2.41
3.80
1.9
1.5
—
—
—
0
0
47
269
1.89
3.60
2.4
1.7
—
—
—
0
0
20
83
2.51
3.38
1.7
1.3
353.33
335.47
ug/g
0.15
12
45
44
252
1.88
3.36
1.6
1.8
3.53
3.56
mmol/l
0.05
29
189
156
1245
1.53
3.27
7.0
6.4
1.21
1.22
mmol/l
0.40
146
1084
7
11
6.49
3.20
1.0
1.1
—
—
—
0
0
98
711
1.56
3.14
1.5
1.3
0.47
1.32
u/ml
1.89
12
210
21
94
2.33
3.04
1.3
2.4
1.72
1.46
g/l
0.42
15
85
228
1998
1.61
2.99
4.8
4.3
11.24
10.56
mm/h
0.28
216
1875
228
2000
1.60
2.95
9.1
7.9
82.78
78.30
u/l
0.43
221
1893
82
580
1.57
2.90
1.6
1.3
2.29
12.41
u/ml
3.66
21
240
86
623
1.54
2.72
1.7
1.4
12.62
32.24
iu/ml
3.66
20
213
10
29
3.53
2.71
1.0
1.2
—
—
—
0
0
10
29
3.53
2.71
1.0
1.2
—
—
—
0
0
93
689
1.51
2.65
1.7
1.6
21.22
22.06
nmol/l
0.23
83
585
239
2139
1.60
2.64
5.0
4.5
14.30
14.62
pmol/l
1.28
233
1983
86
627
1.52
2.64
2.3
2.1
—
—
—
0
0
37
218
1.80
2.60
3.9
3.5
1.53
2.13
mmol/l
0.65
32
197
27
144
1.96
2.56
2.1
1.8
—
—
—
0
0
5
7
7.24
2.56
1.2
1.0
95.00
101.00
%
—
5
7
6
11
5.54
2.55
1.2
2.6
—
—
—
0
0
6
11
5.54
2.55
1.2
2.6
—
—
—
0
0
10
31
3.30
2.54
1.0
1.2
—
—
—
0
0
10
31
3.30
2.54
1.0
1.2
—
—
—
0
0
268
2480
1.83
2.49
6.6
5.5
1.59
1.89
mu/l
7.32
262
2324
12
45
2.74
2.48
2.1
1.5
—
—
—
0
0
215
1892
1.49
2.45
3.4
3.2
44.45
44.00
u/l
0.03
204
1804
28
154
1.90
2.44
1.4
1.4
—
—
—
0
0
51
336
1.63
2.41
1.9
2.0
3.41
3.43
ratio
0.04
35
276
7
17
4.19
2.37
1.4
1.7
—
—
—
0
0
54
363
1.60
2.35
2.7
1.9
—
—
—
0
0
10
34
3.01
2.30
1.0
1.2
—
—
—
0
0
166
1407
1.41
2.21
6.3
6.2
10.88
10.25
umol/l
0.48
159
1338
11
43
2.62
2.10
1.8
1.3
—
—
—
0
0
16
76
2.17
2.06
1.1
1.3
—
—
—
0
0
36
227
1.67
2.02
1.2
1.2
56.11
151.14
u/ml
2.18
13
98
46
309
1.58
2.01
5.4
6.1
103.83
104.08
mmol/l
0.11
46
309
32
196
1.71
2.00
2.8
2.4
66.40
68.08
g/l
0.62
27
184
275
2593
1.82
1.98
20.3
13.6
20.57
20.92
mg/l
0.07
230
2098
270
2535
1.72
1.95
18.2
13.2
86.56
84.04
ml/min/173m2
1.53
248
2344
9
33
2.78
1.95
1.0
1.3
—
—
—
0
0
29
175
1.73
1.91
2.7
1.8
—
—
—
0
0
38
248
1.61
1.88
1.9
4.3
2.48
7.34
ug/l
2.56
28
200
141
1186
1.36
1.86
2.1
1.9
1.40
1.38
mmol/l
0.07
128
1012
6
17
3.58
1.84
1.0
1.1
—
—
—
0
0
44
299
1.55
1.84
2.1
1.8
—
—
—
0
0
59
788
0.69
1.82
2.3
3.0
0.00
0.00
estimate
—
6
226
47
327
1.52
1.77
2.3
1.9
—
—
—
0
0
26
156
1.73
1.76
1.1
1.0
—
—
—
0
0
51
362
1.49
1.75
1.6
1.7
999.37
1159.72
nmol/l
0.76
41
274
6
18
3.38
1.75
2.0
1.4
4.70
2.94
mg/l
—
6
18
7
24
2.96
1.73
1.0
1.0
—
—
—
0
0
7
24
2.96
1.73
1.4
1.2
125.71
105.63
pmol/l
—
7
24
16
83
1.98
1.68
1.1
1.3
—
68.00
—
0
11
87
1075
0.73
1.68
2.7
3.4
0.00
0.02
estimate
—
6
232
8
31
2.62
1.67
1.3
1.2
—
—
—
0
0
10
41
2.49
1.66
1.0
1.2
—
—
—
0
0
8
32
2.54
1.61
1.0
1.0
—
—
—
0
0
27
169
1.66
1.58
1.2
1.3
21.19
29.31
iu/l
0.84
22
142
5
15
3.37
1.53
1.0
1.0
—
—
—
0
0
5
16
3.16
1.44
2.2
1.6
—
—
—
0
0
162
1428
1.30
1.41
3.3
3.6
0.00
0.02
estimate
0.80
11
268
9
41
2.23
1.38
1.3
1.4
—
—
—
0
0
18
291
0.59
1.34
5.4
5.6
—
—
—
0
0
76
609
1.33
1.32
2.2
2.1
3.08
2.83
mg/l
0.21
59
525
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
8
34
2.39
1.30
1.0
1.0
—
—
—
0
0
5
18
2.81
1.29
1.0
1.0
—
—
—
0
0
14
77
1.86
1.27
1.0
1.3
—
0.88
—
0
5
158
1404
1.27
1.23
3.3
3.5
0.00
0.00
estimate
-0.00
11
284
259
2458
1.42
1.21
6.2
6.0
37.87
38.77
mmol/mol
1.25
252
2328
6
129
0.45
1.19
6.3
3.6
1.37
1.65
mmol/l
—
6
95
6
26
2.33
1.19
3.7
4.2
—
—
—
0
0
80
959
0.77
1.17
3.9
3.4
12.07
100.70
ng/l
0.77
38
624
5
20
2.52
1.15
1.0
1.0
—
—
—
0
0
0
36
0.00
1.14
0.0
1.6
—
49.81
—
0
36
7
30
2.36
1.13
1.0
1.0
—
—
—
0
0
7
139
0.49
1.12
1.7
1.5
—
—
—
0
0
21
136
1.59
1.12
2.4
2.5
0.48
0.60
%
1.60
21
136
12
66
1.85
1.10
1.6
1.2
—
—
—
0
0
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
158
1422
1.24
1.04
3.3
3.5
0.00
0.00
estimate
-0.00
12
287
5
23
2.19
0.98
1.4
3.6
1.00
3.48
nmol/l
—
5
23
263
2524
1.37
0.93
5.4
5.0
5.94
5.86
mmol/l
0.39
252
2359
9
52
1.75
0.93
1.3
2.0
—
—
—
0
0
9
52
1.75
0.93
1.7
1.6
—
—
—
0
0
14
86
1.66
0.92
1.4
1.9
1.98
4.88
iu/l
—
5
31
9
154
0.57
0.91
4.9
3.4
5.20
5.13
kpa
—
9
149
36
273
1.36
0.91
2.4
2.0
376.07
368.88
nmol/l
0.07
29
254
12
71
1.72
0.90
1.8
2.7
—
—
—
0
0
18
121
1.52
0.85
1.7
2.1
3.01
2.83
mg/l
0.07
13
94
6
32
1.89
0.82
1.0
1.3
—
—
—
0
0
38
480
0.76
0.82
1.5
1.7
480.00
40633041.03
pmol/l
0.72
31
411
17
114
1.52
0.81
1.2
1.1
1.63
1.59
g/l
0.20
17
114
35
272
1.33
0.77
3.3
2.7
0.66
0.72
ug/l
0.22
22
160
10
60
1.69
0.73
1.8
1.5
—
—
—
0
0
17
118
1.47
0.71
1.2
1.1
0.84
0.93
g/l
0.63
17
118
7
42
1.68
0.69
1.0
1.0
—
—
—
0
0
53
628
0.81
0.68
2.5
3.5
1.02
1.02
kg/l
0.33
27
399
7
43
1.64
0.67
1.4
1.6
—
—
—
0
0
7
44
1.60
0.65
1.9
1.6
—
—
—
0
0
17
121
1.43
0.64
1.4
1.5
0.17
0.33
mg/l
—
6
51
16
221
0.71
0.63
3.0
3.0
—
—
—
0
0
66
570
1.20
0.62
1.3
1.5
—
—
—
0
0
8
53
1.52
0.59
2.0
1.3
—
—
—
0
0
5
87
0.57
0.57
4.8
2.1
—
—
—
0
0
78
690
1.18
0.57
2.3
3.0
625.65
779.75
ng/l
0.37
61
580
14
99
1.43
0.55
1.0
1.3
—
3.11
—
0
14
6
39
1.55
0.53
2.2
1.7
—
—
—
0
0
14
100
1.42
0.53
1.1
1.3
—
2.52
—
0
19
5
33
1.52
0.41
2.2
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
9.00
—
0
19
9
66
1.37
0.38
1.1
1.3
—
—
—
0
0
270
2649
1.21
0.38
6.0
5.8
2.84
2.83
mmol/l
0.09
262
2499
41
357
1.17
0.37
3.8
4.4
21.14
22.18
%
0.14
15
160
22
187
1.19
0.27
2.3
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
4.9
—
4.58
—
0
10
0
10
0.00
0.21
0.0
4.9
—
10.80
—
0
10
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
8.63
—
0
14
8
68
1.18
0.16
2.5
1.5
—
—
—
0
0
8
69
1.16
0.16
2.6
1.6
—
—
—
0
0
265
2622
1.10
0.16
4.9
5.1
4.84
4.82
mmol/l
0.07
253
2476
120
1240
0.95
0.16
2.9
2.6
—
—
estimate
—
0
0
8
73
1.10
0.16
1.5
1.2
—
—
—
0
0
14
123
1.15
0.12
1.5
1.6
—
—
—
0
0
151
1485
1.03
0.08
5.4
4.3
6.41
6.53
mmol/l
0.33
146
1402
9
84
1.07
0.07
1.7
1.4
—
—
—
0
0
11
120
0.91
0.05
1.3
1.4
—
—
—
0
0
250
2489
1.03
0.03
3.8
4.3
1.31
1.30
mmol/l
0.02
234
2333
262
2610
1.03
0.03
4.7
5.0
1.53
1.53
mmol/l
0.02
247
2455
21
218
0.96
0.02
2.2
2.7
83.25
69.46
ml/min/173m2
1.53
12
93
83
837
0.99
0.01
3.5
3.9
4.16
7.38
mg/mmol
0.91
47
497
11
115
0.95
0.00
1.0
1.4
146.70
254.07
miu/ml
—
5
55
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.2
2.5
5.06
6.35
pmol/l
—
5
53
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PROBL_RELATED_PHYSIC_ENVIRONMENT – Problems related to physical environment
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).